Covered recipient · General Payments record
ADAM MAREK BUDNY
Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery
General Payments · PY2018–2024
$172,130.22
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Royalty or License | $8,383.16 | 4 |
| Acquisitions | $3,365.00 | 2 |
| Food and Beverage | $393.21 | 9 |
| Consulting Fee | $150.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| VILEX LLC | $8,383.16 | 4 |
| Linvatec Corporation | $3,521.57 | 7 |
| restor3d, inc. | $176.45 | 1 |
| Winter Innovations, Inc. | $150.00 | 1 |
| Medtronic, Inc. | $31.60 | 1 |
| Smith & Nephew, Inc. | $15.19 | 1 |
| Cumberland Pharmaceuticals, Inc. | $13.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Cumberland Pharmaceuticals, Inc. | $13.40 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146399850 | CMS |
| Linvatec Corporation | $39.67 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147084797 | CMS |
| Linvatec Corporation | $2,507.99 | 01/11/2024 | Acquisitions | Undisputed | 01/23/2026 | 1147084799 | CMS |
| Linvatec Corporation | $12.71 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147084801 | CMS |
| Linvatec Corporation | $32.67 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147084803 | CMS |
| Linvatec Corporation | $857.01 | 04/05/2024 | Acquisitions | Undisputed | 01/23/2026 | 1147084805 | CMS |
| Linvatec Corporation | $51.00 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147084807 | CMS |
| Linvatec Corporation | $20.52 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147084809 | CMS |
| Medtronic, Inc. | $31.60 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117182493 | CMS |
| restor3d, inc. | $176.45 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1068683478 | CMS |
| Smith+Nephew, Inc. | $15.19 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149514319 | CMS |
| VILEX LLC | $1,266.97 | 03/31/2024 | Royalty or License | Undisputed | 01/23/2026 | 1154915923 | CMS |
| VILEX LLC | $1,713.61 | 06/30/2024 | Royalty or License | Undisputed | 01/23/2026 | 1154915967 | CMS |
| VILEX LLC | $2,644.89 | 10/09/2024 | Royalty or License | Undisputed | 01/23/2026 | 1154916065 | CMS |
| VILEX LLC | $2,757.69 | 12/31/2024 | Royalty or License | Undisputed | 01/23/2026 | 1154916181 | CMS |
| Winter Innovations, Inc. | $150.00 | 05/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1073313134 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.